Commentary: The Efficacy of Nerve Growth Factor Antibody for the Treatment of Osteoarthritis Pain and Chronic Low-Back Pain: A Meta-analysis
Main Authors: | Rodrigo R. N. Rizzo, Michael A. Wewege, Hayley B. Leake, James H. McAuley |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-04-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.619344/full |
Similar Items
-
Efficacy, acceptability, and safety of antidepressants for low back pain: a systematic review and meta-analysis
by: Michael C. Ferraro, et al.
Published: (2021-02-01) -
Rescaling pain intensity measures for meta-analyses of analgesic medicines for low back pain appears justified: an empirical examination from randomised trials
by: Michael A. Wewege, et al.
Published: (2022-11-01) -
Efficacy and Safety of Medicines Targeting Neurotrophic Factors in the Management of Low Back Pain: Protocol for a Systematic Review and Meta-analysis
by: Rizzo, Rodrigo R N, et al.
Published: (2021-01-01) -
Using Mediation Analysis to Understand How Treatments for Paediatric Pain Work: A Systematic Review and Recommendations for Future Research
by: Hayley B. Leake, et al.
Published: (2021-02-01) -
The smallest worthwhile effect on pain intensity of nonsteroidal anti-inflammatory drugs and exercise therapy for acute and chronic low back pain: a benefit-harm trade-off study
by: Harrison J Hansford, et al.
Published: (2023-10-01)